Vantage Half-Year Review 2019: Pharma and medtech mega-deals mask drop in M&A activity
The report, published today, analyses stock and market performance, M&A and the financing landscape during the first half of 2019…
Pharmaceuticals, Biotechnology and Life Sciences
The report, published today, analyses stock and market performance, M&A and the financing landscape during the first half of 2019…
DUBLIN–(BUSINESS WIRE)–The “The Market and Potential for Molecular Point of Care Diagnostic Tests 2019” report has been added to ResearchAndMarkets.com’s…
HYDERABAD, India–(BUSINESS WIRE)–#BiologicalE–GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a…
– Second-Quarter Revenue of $657.6 Million – – Second-Quarter GAAP Earnings per Share of $0.88 and Non-GAAP Earnings per Share…
NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces that Gaurav…
KEYTRUDA Now Approved for Recurrent Locally Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus in Patients Whose Tumors Express…
LONDON–(BUSINESS WIRE)–#Biotechnology–Vendors in the market are increasingly focusing on the adoption of more targeted approaches such as anabolic medications for…
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO: 4502/NYSE: TAK) today announces that the Takeda Board of Directors has approved…
Revenue 849.1 billion yen, up +88.8% versus prior year mainly due to acquisition of Shire, with solid performance of 14…
MONTPELLIER, France–(BUSINESS WIRE)–Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical company which specialises in the development of novel therapies to…